A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis

NCT02951182 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: TEZ
DRUG: IVA
DRUG: VX-440
DRUG: Matched Placebo

Sponsor

Vertex Pharmaceuticals Incorporated